What To Know About Aducanumab and Slowing the Progression of Alzheimer Disease

Video

Pharmacy Times spoke to Dr. Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.

Pharmacy Times spoke to Dr.Douglas Scharre, neurologist and director of the division of Cognitive Neurology at Ohio State Wexner Medical Center, about the latest FDA approved drug for Alzheimer disease.

Related Videos
Pharmacy Times Public Health Matters Podcast (logo)
Therapy session -- Image credit: pressmaster | stock.adobe.com
Image credit: goodluz | stock.adobe.com
Elderly woman hands putting missing white jigsaw puzzle piece down into the place as a human brain shape | Image credit: Orawan - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.